Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents

Recruiting now · Not applicable

Conditions studied: Solid Tumor, Adult

In brief

This is a proof-of-principle study, that uses freshly resected human solid tumor specimens to assess the performance of topically applied fluorescent imaging agents for the detection of tumor tissue and close / tumor-positive resection margins ex vivo. Surgery will be performed in conformity with hospital protocol. The study will not interfere with the standard clinical care.

Key facts

Study ID

NCT06292845

Run by

Erasmus Medical Center

People needed

200

Starts

2024-01-16

Expected to finish

2027-12-01

Last updated by the study team

2024-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a biopsy-proven solid tumor, scheduled for surgery at the Erasmus Medical Center.
• Signed and dated informed consent obtained before any study-related procedure is performed.

You may not qualify if…

• Terminated surgical procedure.
• No fresh specimen available.
• Participation in a clinical trial for which the patient receives another fluorophore perioperatively.

Where it is running

• Erasmus University Medical Center — Rotterdam, South Holland, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.